Podcasts about Emory University

How do you grow your revenues without upsetting your existing customers?  In this episode, Colin Shaw and Professor Ryan Hamilton dive into the new book he has written with Anne Wilson, Senior Lecturer at Wharton.  Published by Harvard Business Review Press, the book is called:  The Growth Dilemma: Managing Your Brand When Different Customers Want Different Things Available here: https://bit.ly/3ZCN2wD Professor Ryan Hamilton reveal how brand growth often gets derailed not by bad strategy, but by insufficient attention to how your customer segments relate to each other. You may think your audiences are living on separate islands, but spoiler alert: they're not. They're watching each other, seeing what the other does, and sometimes they don't like it and will move elsewhere.  From Crocs to Prius to the Bud Light fiasco (and yes, even neo-Nazis in New Balance sneakers), this episode pulls no punches. It's a fast-paced, funny, and brutally honest look at why many brands fail to grow—and how you can avoid becoming the following cautionary tale.

Sergio Alberto Gramitto Ricci, associate professor of law at Hofstra University, and Christina Sautter, professor of law at Southern Methodist University, join the Business Scholarship Podcast to discuss their article The Shareholder Democracy Lie. Their co-author is Daniel Greenwood of Hofstra University. This episode is hosted by Andrew Jennings, associate professor of law at Emory University, and was edited by Dean Saridakis, a law student at Emory University.

Dr. John Sweetenham and Dr. Erika Hamilton highlight key abstracts that were presented at ASCO25, including advances in breast and pancreatic cancers as well as remarkable data from the use of structured exercise programs in cancer care. Transcript Dr. Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham. Today, we'll be discussing some of the key advances and novel approaches in cancer care that were presented at the 2025 ASCO Annual Meeting. I'm delighted to be joined again by the chair of the Meeting's Scientific Program, Dr. Erika Hamilton. She is a medical oncologist and director of breast cancer and gynecologic cancer research at the Sarah Cannon Research Institute in Nashville, Tennessee.  Our full disclosures are available in the transcript of this episode. Dr. Hamilton, congratulations on a fantastic meeting. From the practice-changing science to the world-renowned speakers at this year's Meeting, ASCO25 really reflected the amazing progress we're seeing in oncology today and the enormous opportunities that lie ahead of us. And thanks for coming back on to the podcast today to discuss some of these advances. Dr. Hamilton: Thanks, Dr. Sweetenham. I'm happy to join you today. It really was an impactful ASCO Annual Meeting. I probably am biased, but some great research was presented this year, and I heard lots of great conversations happening while we were there. Dr. Sweetenham: Yeah, absolutely. There was a lot of buzz, as well as a lot of media buzz around the meeting this year, and I think that's probably a good place to start. So I'd like to dive into abstract number LBA3510. This was the CHALLENGE trial, which created a lot of buzz at the meeting and subsequently in the media. This is the study that was led by the NCI Canada Clinical Trials Group, which was the first randomized phase 3 trial in patients with stage III and high-risk stage II colon cancer, which demonstrated that a post-treatment structured exercise program is both feasible and effective in improving disease-free survival in this patient group. The study was performed over a long period of time and in many respects is quite remarkable. So, I wonder if you could give us your thoughts about this study and whether you think that this means that our futures are going to be full of structured exercise programs for those patients who may benefit. Dr. Hamilton: It's a fantastic question. I think that this abstract did create a lot of buzz. We were very excited when we read it. It was highlighted in one of the Clinical Science Symposium sessions. But briefly, this was a phase 3 randomized trial. It was conducted at 55 centers, so really a broad experience, and patients that had resected colon cancer who completed adjuvant therapy were allowed to participate. There were essentially 2 groups: a structured exercise program, called ‘the exercise group,' or health education materials alone, so that was called just ‘the health education group.' And this was a 3-year intervention, so very high quality. The primary end point, as you mentioned, was disease-free survival. This actually accrued from 2009 to 2024, so quite a lift, and almost 900 patients underwent randomization to the exercise group or the health education group. And at almost 8 years of follow-up, we saw that the disease-free survival was significantly longer in the exercise group than the health education group. This was essentially 80.3% of patients were disease-free in exercise and 73.9% in the health education group. So a difference of over 6 percentage points, which, you know, at least in the breast cancer world, we make decisions about whether to do chemotherapy or not based on these kind of data. We also looked at overall survival in the exercise group and health education group, and the 8-year overall survival was 90.3% in the exercise group and 83.2% in the health education group. So this was a difference of 7.1%. Still statistically significant. I think this was really a fantastic effort over more than a decade at over 50 institutions with almost 900 patients, really done in a very systematic, high-intervention way that showed a fantastic result. Absolutely generalizable for patients with colon cancer. We have hints in other cancers that this is beneficial, and frankly, for our patients for other comorbidities, such as cardiovascular, etc., I really think that this is an abstract that deserved the press that it received. Dr. Sweetenham: Yeah, absolutely, and it is going to be very interesting, I think, over the next 2 or 3 years to see how much impact this particular study might have on programs across the country and across the world actually, in terms of what they do in this kind of adjuvant setting for structured exercise. Dr. Hamilton: Absolutely.  So let's move on to Abstract 3006. This was an NCI-led effort comparing genomic testing using ctDNA and tissue from patients with less common cancers who were enrolled in but not eligible for a treatment arm of the NCI-MATCH trial. Tell us about your takeaways from this study. Dr. Sweetenham: Yeah, so I thought this was a really interesting study based, as you said, on NCI-MATCH. And many of the listeners will probably remember that the original NCI-MATCH study screened almost 6,000 patients to assess eligibility for those who had an actionable mutation. And it turned out that about 60% of the patients who went on to the study had less common tumors, which were defined as anything other than colon, rectum, breast, non–small cell lung cancer, or prostate cancer. And most of those patients lacked an eligible mutation of interest and so didn't get onto a trial therapy. But with a great deal of foresight, the study group had actually collected plasma samples from these patients so that they would have the opportunity to look at circulating tumor DNA profiles with the potential being that this might be another way for testing for clinically relevant mutations in some of these less common cancer types. So initially, they tested more than 2,000 patients, and to make a somewhat complicated story short, there was a subset of five histologies with a larger representation in terms of sample size. And these were cholangiocarcinoma, small cell lung cancer, esophageal cancer, pancreatic, and salivary gland cancer. And in those particular tumors, when they compared the ctDNA sequencing with the original tumor, there was a concordance there of around 84%, 85%. And in the presentation, the investigators go on to list the specific mutated genes that were identified in each of those tumors. But I think that the other compelling part of this study from my perspective was not just that concordance, which suggests that there's an opportunity there for the use of ctDNA instead of tumor biopsies in some of these situations, but what was also interesting was the fact that there were several clinically relevant mutations which were detected only in the circulating tumor DNA. And a couple of examples of those included IDH1 for cholangiocarcinoma, BRAF and p53 in several histologies, and microsatellite instability was most prevalent in small cell lung cancer in the ctDNA. So I think that what this demonstrates is that liquid biopsy is certainly a viable screening option for patients who are being assessed for matching for targeted therapies in clinical trials. The fact that some of these mutations were only seen in the ctDNA and not in the primary tumor specimen certainly suggests that there's some tumor heterogeneity. But I think that for me, the most compelling part of this study was the fact that many of these mutations were only picked up in the plasma. And so, as the authors concluded, they believe that a comprehensive gene profiling with circulating tumor DNA probably should be included as a primary screening modality in future trials of targeted therapy of this type. Dr. Hamilton: Yeah, I think that that's really interesting and mirrors a lot of data that we've been seeing. At least in breast cancer, you know, we still do a biopsy up front to make sure that our markers, we're still treating the right disease that we think we are. But it really speaks to the utility of using ctDNA for serial monitoring and the emergence of mutations. Dr. Sweetenham: Absolutely. And you mentioned breast cancer, and so I'd like to dwell on that for a moment here because obviously, there was a huge amount of exciting breast cancer data presented at the meeting this year. And in particular, I'd like to ask you about LBA1008, the DESTINY-Breast09 clinical trial, which I think has the potential to establish a new first-line standard of care for metastatic HER2+ breast cancer. And that's an area where we haven't seen a whole lot of innovation for around a decade now. So can you give us some of the highlights of this trial and what your thinking is, having seen the results? Dr. Hamilton: Yeah, absolutely. So this was a trial in the first-line metastatic HER2 setting. So this was looking at trastuzumab deruxtecan. We certainly have had no shortage of reports around this drug, initially approved for later lines. DESTINY-Breast03 brought it into our second-line setting for HER2+ disease and we're now looking at DESTINY-Breast09 in first-line. So this actually was a 3-arm trial where patients were randomized 1:1:1 against standard taxane/trastuzumab/pertuzumab in one arm; trastuzumab deruxtecan with pertuzumab in another arm; and then a third arm, trastuzumab deruxtecan alone. And what we did not see reported was that trastuzumab deruxtecan-alone arm. But we did have reports from the trastuzumab deruxtecan plus pertuzumab versus the chemo/trastuzumab/pertuzumab. And what we saw was a statistically significant improvement in median progression-free survival, 26.9 months up to 40.7, so an improvement of 13.8 months, over a year in PFS. Not to mention that we're now in the 40-month range for PFS in first-line disease. Really, across all subgroups, we really weren't able to pick out a subset of patients that did not benefit. We did see about a 12% ILD rate with trastuzumab deruxtecan. That really is on par with what we've seen in other studies, around 10%-15%. I think that this is going to become a new standard of care in the first-line. I think it did leave some unanswered questions. We saw some data from the PATINA trial this past San Antonio Breast, looking at the addition of endocrine therapy with or without a CDK4/6 inhibitor, palbociclib, for those patients that also have ER+ disease, after taxane has dropped out in the first-line setting. So how we're going to kind of merge all this together is, I suspect that there are going to be patients that we or they just don't have the appetite to continue 3 to 4 years of trastuzumab deruxtecan. And so we're probably going to be looking at a maintenance-type strategy for them, maybe integrating the PATINA data there. But how we really put this into practice in the first-line setting and if or when we think about de-escalating down from trastuzumab deruxtecan to antibody therapy are some lingering questions. Dr. Sweetenham: Okay, so certainly is going to influence practice, but watch this space for a little bit longer, it sounds as though that's what you're saying. Dr. Hamilton: Absolutely.  So let's move on to GI cancer. Abstract 4006 reported preliminary results from the randomized phase 2 study of elraglusib in combination with gemcitabine/nab-paclitaxel versus the chemo gemcitabine/nab-paclitaxel alone in patients with previously untreated metastatic pancreatic cancer. Can you tell us more about this study? Dr. Sweetenham: Yeah, absolutely. As you mentioned, elraglusib is actually a first-in-class inhibitor of GSK3-beta, which has multiple potential actions in pancreatic cancer. But the drug itself may be involved in mediating drug resistance as well as in some tumor immune response modulation. Some of that's not clearly understood, I believe, right now. But certainly, preclinical data suggests that the drug may be effective in preclinical models and may also be effective in combination with chemotherapy and potentially with immune-modulating agents as well. So this particular study, as you said, was an open-label, randomized phase 2 study in which patients with pancreatic cancer were randomized 2:1 in favor of the elraglusib plus GMP—gemcitabine and nab-paclitaxel—versus the chemotherapy alone. And upon completion of the study, which is not right now, median overall survival was the primary end point, but there are a number of other end points which I'll talk about in just a moment. But the sample size was planned to be around 207 patients. The primary analysis included 155 patients in the combination arm versus 78 patients in the gemcitabine/nab-paclitaxel arm. Overall, the 1-year overall survival rate was 44.1% for the patients in the elraglusib-containing arm versus 23.0% in the patients receiving gemcitabine/nab-paclitaxel only. When they look at the median overall survival, it was 9.3 months for the experimental arm versus 7.2 months for chemotherapy alone. So put another way, there's around a 37% reduction in the risk of death with the use of this combination arm. The treatment was overall well-tolerated. There were some issues with grade 1 to 2 transient visual impairment in a large proportion of the patients. The most common treatment-related adverse effects with the elraglusib/GMP combination was transient visual impairment, which affected around 60% of the patients. Most of the more serious treatment-related adverse events included neutropenia, anemia, and fatigue in 50%, 25%, and 16% of the patients, respectively. So the early results from this study show a significant benefit for 1-year overall survival and for median overall survival with, as I mentioned above, a significant reduction in the risk of death. The authors went on to mention that the median overall survival for the control arm in this study is somewhat lower than in other comparable trials, but they think that this may be related to a more advanced disease burden in this particular study. Of interest to me was that right now: there is no apparent difference in progression-free survival between the 2 arms of this study. The authors described this as potentially indicating that this may be related in some way to immune modulation and immune effects on the tumor, which, if I'm completely honest, I don't totally understand. And so, the improvement in overall survival, as far as I can see at the moment, is not matched by an improvement in progression-free survival. So I think we probably need to wait for more time to elapse to see what happens with the study. And so, I think it certainly is an interesting study, and the results are intriguing, but I think it's probably a little early for it to actually shift the treatment paradigm in this disease. Dr. Hamilton: Fantastic. I think we've been waiting for advances in pancreatic cancer for a long time, but this, not unlike others, we learn more and then learn more we don't realize, so. Dr. Sweetenham: Right. Let's shift gears at this point and talk about a couple of other abstracts in kind of a very different space. Let's start out with symptom management for older adults with cancer. We know that undertreated symptoms are common among the older patient population, and Abstract 11002 reported on a randomized trial that demonstrated the effects of remote monitoring for older patients with cancer in terms of kind of symptoms and so on. Can you tell us a little bit about this study and whether you think this approach will potentially improve care for older patients? Dr. Hamilton: Yeah, I really liked this abstract. It was conducted through the Veterans Affairs, and it was based in California, which I'm telling you that because it's going to have a little bit of an implication later on. But essentially, adults that were 75 years or older who were Medicare Advantage beneficiaries were eligible to participate. Forty-three clinics in Southern California and Arizona, and patients were randomized either into a control group of usual clinic care alone, or an intervention group, which was usual care plus a lay health worker-led proactive telephone-based weekly symptom assessment, and this was for 12 months using the validated Edmonton Symptom Assessment System. So, there was a planned enrollment of at least 200 patients in each group. They successfully met that. And this lay health worker reviewed assessments with a physician assistant, who conducted follow-up for symptoms that changed by 2 points from a prior assessment or were rated 4 or greater. So almost a triage system to figure out who needed to be reached out to and to kind of work on symptoms. What I thought was fantastic about this was it was very representative of where it enrolled. There were actually about 50% of patients enrolled here that were Hispanic or Latinos. So some of our underserved populations and really across a wide variety of tumor types. They found that the intervention group had 53% lower odds of emergency room use, 68% lower odds of hospital use than the control group. And when they translated this to actual total cost of care, this was a savings of about $12,000 U.S. per participant and 75% lower odds of a death in an acute care facility. So I thought this was really interesting for a variety of reasons. One, certainly health care utilization and cost, but even more so, I think any of our patients would want to prevent hospitalizations and ER visits. Normally, that's not a fantastic experience having to feel poorly enough that you're in the emergency room or the hospital. And really showing in kind of concrete metrics that we were able to decrease this with this intervention. In terms of sustainability and scalability, I think the question is really the workforce to do this. Obviously, you know, this is going to take dedicated employees to have the ability to reach out to these patients, etc., but I think in value-based care, there's definitely a possibility of having reimbursement and having the funds to institute a program like this. So, definitely thought-provoking, and I hope it leads to more interventions. Dr. Sweetenham: Yeah, we've seen, over several years now, many of these studies which have looked at remote symptom monitoring and so on in this patient population, and many of them do show benefits for that in kinds of end points, not the least in this study being hospitalization and emergency room avoidance. But I think the scalability and personnel issue is a huge one, and I do wonder at some level whether we may see some AI-based platforms coming along that could actually help with this and provide interactions with these patients outside of actual real people, or at least in combination with real people. Dr. Hamilton: Yeah, that's a fantastic point.  So let's talk a little bit about clinical trials. So eligibility assessment for oncology clinical trials, or prescreening, really relies on manual review of unstructured clinical notes. It's time-consuming, it's prone to errors, and Abstract 1508 reported on the final analysis of a randomized trial that looked at the effect of human-AI teams prescreening for clinical trial eligibility versus human-only or AI-only prescreening. So give us more good news about AI. What did the study find? Dr. Sweetenham: Yeah, this is a really, a really interesting study. And of course, any of us who have ever been involved in clinical trials will know that accrual is always a problem. And I think most centers have attempted, and some quite successfully managed to develop prescreening programs so that patients are screened by a health care provider or health care worker prior to being seen in the clinic, and the clinical investigator will then already know whether they're going to be eligible for a trial or not. But as you've already said, it's a slow process. It's typically somewhat inefficient and requires a lot of time on the part of the health care workers to actually do this in a successful way. And so, this was a study from Emory University where they took three models of ways in which they could assess the accuracy of the prescreening of charts for patients who are going to be considered for clinical trials. One of these was essentially the regular way of having two research coordinators physically abstract the charts. The second one was an AI platform which would extract longitudinal EHR data. And then the third one was a combination of the two. So the AI would be augmented by the research coordinator or the other way around. As a gold standard, they had three independent oncology reviewers who went through all of these charts to provide what they regarded as being the benchmark for accuracy. In a way, it's not a surprise to me because I think that a number of other systems which have used this combination of human verification of AI-based tools, it actually ultimately concluded that the combination of the two in terms of chart accuracy was for the most part better than either one individually, either the research coordinator or the AI alone. So I'll give you just a few examples of where specifically that mattered. The human plus AI platform was more accurate in terms of tumor staging, in terms of identifying biomarker testing and biomarker results, as well as biomarker interpretation, and was also superior in terms of listing medications. There are one or two other areas where either the AI alone was somewhat more accurate, but the significant differences were very much in favor of a combination of human + AI screening of these patient charts. So, in full disclosure, this didn't save time, but what the authors reported was that there were definite efficiency gains, and presumably this would actually become even more improved once the research coordinators were somewhat more comfortable and at home with the AI tool. So, I thought it was an interesting way of trying to enhance clinical trial accrual up front by this combination of humans and technology, and I think it's going to be interesting to see if this gets adopted at other centers in the future. Dr. Hamilton: Yeah, I think it's really fascinating, all the different places that we can be using AI, and I love the takeaway that AI and humans together are better than either individually. Dr. Sweetenham: Absolutely.  Thanks once again, Dr. Hamilton, for sharing your insights with us today and for all of the incredible work you did to build a robust program. And also, congratulations on what was, I think, a really remarkable ASCO this year, one of the most exciting for some time, I think. So thank you again for that. Dr. Hamilton: Thanks so much. It was really a pleasure to work on ASCO 2025 this year. Dr. Sweetenham: And thank you to our listeners for joining us today. You'll find links to all the abstracts we discussed today in the transcript of this episode. Be sure to catch up on all of our coverage from the Annual Meeting. You can catch up on my daily reports that were published each day of the Annual Meeting, featuring the key science and innovations presented. And we'll have wrap-up episodes publishing in June, covering the full spectrum of malignancies from ASCO25. If you value the insights you hear on the ASCO Daily News Podcast, please remember to rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   More on today's speakers: Dr. John Sweetenham   Dr. Erika Hamilton @erikahamilton9   Follow ASCO on social media:  @ASCO on Twitter  ASCO on Bluesky  ASCO on Facebook   ASCO on LinkedIn     Disclosures:     Dr. John Sweetenham:     No relationships to disclose    Dr. Erika Hamilton: Consulting or Advisory Role (Inst): Pfizer, Genentech/Roche, Lilly, Daiichi Sankyo, Mersana, AstraZeneca, Novartis, Ellipses Pharma, Olema Pharmaceuticals, Stemline Therapeutics, Tubulis, Verascity Science, Theratechnologies, Accutar Biotechnology, Entos, Fosun Pharma, Gilead Sciences, Jazz Pharmaceuticals, Medical Pharma Services, Hosun Pharma, Zentalis Pharmaceuticals, Jefferies, Tempus Labs, Arvinas, Circle Pharma, Janssen, Johnson and Johnson   Research Funding (Inst): AstraZeneca, Hutchison MediPharma, OncoMed, MedImmune, Stem CentRx, Genentech/Roche, Curis, Verastem, Zymeworks, Syndax, Lycera, Rgenix, Novartis, Millenium, TapImmune, Inc., Lilly, Pfizer, Lilly, Pfizer, Tesaro, Boehringer Ingelheim, H3 Biomedicine, Radius Health, Acerta Pharma, Macrogenics, Abbvie, Immunomedics, Fujifilm, eFFECTOR Therapeutics, Merus, Nucana, Regeneron, Leap Therapeutics, Taiho Pharmaceuticals, EMD Serono, Daiichi Sankyo, ArQule, Syros Pharmaceuticals, Clovis Oncology, CytomX Therapeutics, InventisBio, Deciphera, Sermonix Pharmaceuticals, Zenith Epigentics, Arvinas, Harpoon, Black Diamond, Orinove, Molecular Templates, Seattle Genetics, Compugen, GI Therapeutics, Karyopharm Therapeutics, Dana-Farber Cancer Hospital, Shattuck Labs, PharmaMar, Olema Pharmaceuticals, Immunogen, Plexxikon, Amgen, Akesobio Australia, ADC Therapeutics, AtlasMedx, Aravive, Ellipses Pharma, Incyte, MabSpace Biosciences, ORIC Pharmaceuticals, Pieris Pharmaceuticals, Pieris Pharmaceuticals, Pionyr, Repetoire Immune Medicines, Treadwell Therapeutics, Accutar Biotech, Artios, Bliss Biopharmaceutical, Cascadian Therapeutics, Dantari, Duality Biologics, Elucida Oncology, Infinity Pharmaceuticals, Relay Therapeutics, Tolmar, Torque, BeiGene, Context Therapeutics, K-Group Beta, Kind Pharmaceuticals, Loxo Oncology, Oncothyreon, Orum Therapeutics, Prelude Therapeutics, Profound Bio, Cullinan Oncology, Bristol-Myers Squib, Eisai, Fochon Pharmaceuticals, Gilead Sciences, Inspirna, Myriad Genetics, Silverback Therapeutics, Stemline Therapeutics

Season 12 is all about PLEASURE and we're kicking things off with a juicy one! This week, DB is joined by Dr. Candice Nicole Hargons—licensed psychologist, sex researcher, and pleasure activist—to talk about what happened when 1,000 people with masturbate for science! The Magic Wand Wellness Study is the first study of its kind to look at how daily masturbation impacts things like sleep, stress, focus, confidence, and body image, and the results were amazing. We talk about why solo pleasure is so often ignored in wellness culture, what DB learned from doing the study herself, and why taking time to get yourself off might actually make you feel better in your body, your brain, and your relationships. If you've been feeling disconnected from your pleasure — especially solo pleasure — this is your gentle nudge (or loud, vibrating one) to come back to it! GUEST DETAILS Dr. Candice Nicole Hargons is an award-winning associate professor at Emory University's Rollins School of Public Health, where she studies sexual wellness and liberation. She has published over 80 academic articles and has been featured in popular media, including Cosmopolitan, Wall Street Journal, New York Times, Essence, Ebony, and the Huffington Post. Her debut book, Good Sex: Stories, Science, and Strategies for Sexual Liberation was published February 2025 by Row House. ABOUT SEASON 12 Season 12 of Sex Ed with DB is ALL ABOUT PLEASURE! Solo pleasure. Partnered pleasure. Orgasms. Porn. Queer joy. Kinks, sex toys, fantasies—you name it. We're here to help you feel more informed, more empowered, and a whole lot more turned on to help YOU have the best sex. CONNECT WITH US Instagram: @sexedwithdbpodcast TikTok: @sexedwithdbTwitter: @sexedwithdbThreads: @sexedwithdbpodcast YouTube: Sex Ed with DB SEX ED WITH DB SEASON 12 SPONSORS Lion's Den, Uberlube, & Magic Wand Get discounts on all of DB's favorite things here! GET IN TOUCH Email: sexedwithdb@gmail.comSubscribe to our BRAND NEW newsletter for hot goss, expert advice, and *the* most salacious stories. FOR SEXUAL HEALTH PROFESSIONALS Check out DB's workshop: "Building A Profitable Online Sexual Health Brand" ABOUT THE SHOW Sex Ed with DB is your go-to podcast for smart, science-backed sex education—delivering trusted insights from top experts on sex, sexuality, and pleasure. Empowering, inclusive, and grounded in real science, it's the sex ed you've always wanted. ASK AN ANONYMOUS SEX ED QUESTION Fill out our anonymous form to ask your sex ed question. SEASON 12 TEAM Creator, Host & Executive Producer: Danielle Bezalel (DB) (she/her) Producer: Sadie Lidji (she/her) Communications Lead: Cathren Cohen (she/her) Growth Marketing Manager: Wil Williams (they/them) MUSIC Intro theme music: Hook Sounds Background music: Bright State by Ketsa Ad music: Soul Sync by Ketsa and Soul Trap by Ketsa

Join us for an inspiring conversation with Dr. Scott JN McNabb as he takes us on a fascinating journey through his public health career — from the lab bench to leadership roles at the CDC and Emory University. Discover how mentorship fueled his passion for tackling some of the world's toughest health challenges, including those in conflict zones. Dive deep into the cutting-edge world of public health surveillance and learn how innovative technologies like ethical AI are revolutionizing the way we collect and communicate vital health data. Dr. McNabb shares candid insights on overcoming communication hurdles and the exciting possibilities that come from integrating health systems and collaborating across disciplines. Whether you're an epidemiologist, public health professional, or simply curious about how data shapes global health, this episode is packed with stories and ideas that will challenge and inspire you.   Resources   ▶️ Join the PHEC Community   ▶️ Visit the PHEC Podcast Show Notes    ▶️ DrCHHuntley, Public Health & Epidemiology Consulting

GDP Script/ Top Stories for June 17th Publish Date: June 17th From The BG AD Group Studio, Welcome to the Gwinnett Daily Post Podcast. Today is Tuesday, June 17th and Happy Birthday to Roberto Duran. I’m Keith Ippolito and here are your top stories presented by KIA Mall of Georgia Man who started fire in Norcross to evade ICE agents headed to prison Gwinnettians denounce Trump policies during 'No Kings' protest Snellville Police Say 2 Arrested In Connection To Shooting At Briscoe Park All of this and more is coming up on the Gwinnett Daily Post podcast, and if you are looking for community news, we encourage you to listen and subscribe! Break 1: Kia MOG (07.14.22 KIA MOG) STORY 1: Man who started fire in Norcross to evade ICE agents headed to prison Armando Carrillo-Diaz, a 45-year-old undocumented immigrant from Mexico, was sentenced to five years in federal prison for arson, assaulting a federal officer, and illegal reentry into the U.S. In December 2022, he attacked a Gwinnett police officer with a machete. In April 2023, he fled from ICE agents in his truck. In July 2023, he set fire to his Norcross apartment to evade arrest, displacing 20-30 residents and injuring himself. Federal prosecutors highlighted his dangerous actions, which endangered law enforcement and the public. The case involved multiple agencies, emphasizing the commitment to holding individuals accountable for reckless and violent behavior. STORY 2: Gwinnettians denounce Trump policies during 'No Kings' protest This weekend, over 1,500 people gathered in Suwanee for a 'No Kings' protest against President Trump's policies. Organized by local volunteer Kevin Vazquez, the event aimed to highlight concerns over women's rights, immigration, and the administration's direction. Suwanee resident Maria King-Smart joined to advocate for democracy, declaring, 'History repeats itself, and I don’t want it to.' Protestors held signs like 'Defend Democracy' and 'No Kings Since 1776.' The peaceful demonstration contrasted with clashes at protests elsewhere. The event emphasized community unity, with Gwinnett County’s diverse voices calling for change. State Rep. Jasmine Clark labeled Trump a 'parasite' needing history lessons. STORY 3: Snellville Police Say 2 Arrested In Connection To Shooting At Briscoe Park In Snellville authorities have arrested two teenagers in connection to the May 31 shooting at Briscoe Park, which left six people injured. Police say 17-year-old Joshua Senai Zere of Stone Mountain was taken into custody on June 11 and faces five counts of party to a crime of aggravated assault. The next day, 17-year-old Eric Meier Harris of Dacula was arrested, charged with four counts of aggravated assault. Thankfully, all victims are expected to recover. For more details or to assist with the investigation, contact Lt. Trey Downs at tdowns@snellville.org. We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info. We’ll be right back Break 2: Ingles Markets 1 STORY 4: ‘A real mess’ — Homeless camp frustrates property owners while its cleanup leaves residents scrambling Robby Workman and Faith Zilka, a homeless couple in Norcross, have faced repeated displacement after makeshift shelters they built near I-85 were bulldozed. Struggling to stay dry amidst constant rain, they now wander the streets, battling trench foot and exhaustion. Denied stable shelter, the pair survives by collecting scrap metal, yet earn only enough for basics like food. Workman dreams of buying a vehicle to improve their situation, but obstacles remain. Local businesses, citing cleanliness and safety concerns, have pressured authorities to clear camps. Despite hardships, Workman warns, 'Anyone is one paycheck away from being here.' Their resilience remains unwavering. STORY 5: Piedmont Eastside Medical Center Opens Neurology Practice Piedmont Eastside Medical Center welcomed neurologists Dr. Ogonna Iwuora [Oh-GOH-nah Ee-WOR-ah] and Dr. Paula Lee to Piedmont Neurology at Eastside. Located on Tree Lane, the practice now offers advanced treatments for conditions like epilepsy, dementia, and headaches. Dr. Iwuora, board-certified in neurology and neurophysiology, completed her fellowship at Emory University and specializes in dementia and epilepsy care. Dr. Lee brought over a decade of expertise, focusing on refractory epilepsy and therapies like RNS and VNS. She trained at Tufts Medical Center and Northwestern Memorial Hospital. Accepting new patients, the team provides personalized care options with modern, non-invasive techniques. Break: STORY 6: Summer school is a time to get ahead at Georgia Gwinnett College This summer, a record 5,300 students enrolled at Georgia Gwinnett College, proving summer isn’t just for vacations. Many are earning credits to graduate early, boosting GPAs, or exploring new subjects. Nursing student Phoenix Winbush says summer classes help her stay focused, earning top grades. IT major Isaiah Jones uses the term to explore history and psychology. With compressed five-week courses, students like Winbush emphasize the need for discipline. Financial aid is available for eligible students, but Assistant Director Jacqueline Garcia Mendez advises balancing workloads to stay on track. For some, like visiting student Sara Swope, GGC’s atmosphere and professors are a major draw. STORY 7: NCG Cinemas opening new Snellville theater this weekend NCG Cinemas celebrated the grand opening of its new location in Snellville’s Presidential Markets shopping center last Friday. The event kicked off with a ribbon cutting and a VIP night featuring free screenings of movies like 'How To Train Your Dragon' and 'Karate Kid Legends.' The theater, located at 1905 Scenic Highway North, boasts luxury reclining seats and the world’s first Klipsch Studio Experience sound system, offering top-notch audio. Formerly an AMC theater, NCG aims to revamp the moviegoing experience. Tickets are now available online, welcoming movie lovers to enjoy the pinnacle of cinematic entertainment in Snellville. Break 4: Signoff – Thanks again for hanging out with us on today’s Gwinnett Daily Post Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.gwinnettdailypost.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com  www.kiamallofga.com #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

"When it comes to caregiving, the assumption about being able to take what we've learned and just naturally grow is not always going to be true." How do you think you would feel if you were caregiving for a second or third person living with dementia? Would you feel more prepared because of your previous experience? If you answered "yes," you might be surprised by what research is revealing about experienced caregivers. We are Sue Ryan and Nancy Treaster. As caregivers for our loved ones with Alzheimer's and other types of dementia, both of us have been caregivers more than once, and we recently learned about enlightening research from Dr. Emily Mroz, a researcher at Emory University's School of Nursing who coined the phrase "experienced caregiver." Her research is shedding light on a common phenomenon that affects millions of families: providing dementia care for multiple loved ones throughout adulthood. Dr. Mroz is a tenure-track assistant professor and social behavioral scientist who studies how people think, feel, and act within their social and personal situations. With training in developmental psychology, gerontology, geriatrics, and public health, she uses her multidisciplinary perspective to develop resources and interventions that support people living with serious illness, family caregivers, and those who are bereaved. Through her research and interviews with caregivers, Dr. Mroz has identified crucial insights about experienced caregivers that challenge common assumptions and offer practical guidance for those stepping into the caregiving role again. Full Show Notes https://thecaregiversjourney.org/37-studying-experienced-caregivers-four-essential-tips-alzheimers-and-other-dementias/ Additional Resources Mentioned Dr. Emily Mroz, assistant professor and social-behavioral scientist, discusses her research on improving how patients and caregivers navigate serious illnesses such as dementia, end-of-life care and bereavement. Link to study flyer here To join this study, visit survey.qualtrics.emory.edu/jfe/form/SV_cYfshxWcThSSV5s.Support the nonprofit The Caregiver's Journey: https://give.cornerstone.cc/thecaregiversjourney Takeaways Tip 1: Avoid Assumptions About Who Is Prepared to Be a Dementia Caregiver Tip 2: Assess How Prepared You Really Feel Tip 3: Don't Hesitate to Get Involved in Skills Training and Support Groups Tip 4: Share Your Stories with Grace, Not Judgment The Importance of Research for Experienced Caregivers Dr. Mroz's study is part of a growing recognition that experienced caregivers represent a significant population with unique needs and strengths. Her virtual research study involves participants completing surveys about their caregiving experiences and sharing their stories to help researchers understand the differences between new and experienced caregivers. Study details: Focuses on people currently in active caregiving roles, including those early in their journey with a second or third care recipientParticipants receive a $50 gift card honorariumSessions are conducted virtually and take about one to two hoursCan participate alongside other dementia caregiver research studiesResearch is crucial for developing resources specifically tailored to experienced caregivers Read More in This Blog here

Originally from Trinidad and Tobago, Arlene is a community psychologist who recently retired from the CDC.  While there she worked as a behavioral scientist focusing on capacity building as it relates to HIV prevention.  She received her BA in Psychology from the University of Tampa, MA in Counseling and Human Development from Clark Atlanta University and PhD in Community Psychology from Georgia State University.  After beginning her public health work, she realized a need to augment her education and completed an MPH from Emory University.  Arlene is also a veteran and retired from the US Army Reserve with the rank of Lieutenant Colonel.  As a Black lesbian her work and adult life has included finding ways to show up in an authentic manner and make space for others to do the same.  Currently she works as a consultant on an HIV prevention project focused on encouraging Black women to view PrEP usage as an act of self-care, she is also growing a garden and a forest.

CTL Script/ Top Stories of June 13th Publish Date: June 13th   Pre-Roll: From the Ingles Studio Welcome to the Award-Winning Cherokee Tribune Ledger Podcast  Today is Friday, June 13th and Happy Birthday to Tim Allen I’m Peyton Spurlock and here are the stories Cherokee is talking about, presented by Times Journal Cherokee County Students Win Gold in Summer Special Olympics GDOT Wants Your Input on Towne Lake Parkway and I-575 Bomb Babes Opens at The Outlet Shoppes in Woodstock Plus, Leah McGrath from Ingles Markets on sodas We’ll have all this and more coming up on the Cherokee Tribune-Ledger Podcast, and if you’re looking for Community news, we encourage you to listen and subscribe!  Commercial: MILL ON ETOWAH REV GENERIC_FINAL STORY 1: Cherokee County Students Win Gold in Summer Special Olympics Cherokee County School District students excelled at the 2025 State Summer Special Olympics, earning gold in various events at Emory University. The Cherokee County Special Olympics soccer team won gold, while individual students claimed top honors in cheer, flag football, soccer, swimming, and track. Notable achievements include standout performances in swimming by Otto Arreaza and Daniel Cannon, and track victories by Imani Cherry and Lorelei Lyu. The Olympians will be honored at an upcoming school board meeting alongside Adapted PE teacher and Special Olympics coordinator Ben Farist. STORY 2: GDOT Wants Your Input on Towne Lake Parkway and I-575 The Georgia Department of Transportation (GDOT) and the Federal Highway Administration are seeking public input on proposed improvements to the I-575 and Towne Lake Parkway interchange in Cherokee County. Public comments can be submitted online through July 7 via GDOT’s project website. The $12.9 million project, funded by federal and local contributions, aims to enhance traffic flow with added turn lanes, wider shoulders, and intersection upgrades. Improvements include extended turn lanes on Towne Lake Parkway and I-575 ramps, as well as additional lanes and turn options at the Woodstock Parkway intersection. Public input is encouraged to shape the project. STORY 3: Bomb Babes Opens at The Outlet Shoppes in Woodstock Bomb Babes, a gourmet cake bomb bakery founded by Kathryn Cruz, celebrated the opening of its first storefront in Woodstock on June 10. Previously operating from her home kitchen and pop-up events, Cruz launched the brick-and-mortar location at The Outlet Shoppes of Atlanta on May 23. Known for oversized cake truffles, Bomb Babes evolved from a hot chocolate bomb business. Cruz, recently named one of Cherokee County’s Top 10 in 10 Young Professionals, credits local support and entrepreneurial programs for her success. With plans to franchise next year, Cruz aims to make Bomb Babes a household name like Crumbl Cookies. We have opportunities for sponsors to get great engagement on these shows. Call 770.874.3200 for more info.    Break: STORY 4: Cherokee Sheriff’s Foundation Announces Scholarship Recipients The Cherokee Sheriff’s Foundation has announced its 2025 college scholarship recipients, awarding $1,000 scholarships to 10 students. These scholarships honor the children of Cherokee Sheriff’s Office and Marshals Office employees for their academic excellence and community service. This year’s recipients are Anabelle Jordan, Anakate Cox, Autumn Herrin, Avery Shaw, Issac Martin, Jaden Bedoya, Katelynn Carter, Shaun Pinyan, Sophie Baker, and Thomas Pinyan III. For more information or to support the foundation, visit their website. STORY 5: How to Vote Absentee in Cherokee’s Aug. 26 Elections Applications for absentee ballots are now open for Cherokee County’s Aug. 26 special elections, which will fill the Georgia Senate District 21 and Cherokee County Board of Commissioners District 1 seats. Eligible voters can apply online, by mail, fax, email, or in person, with the deadline to apply set for Aug. 15. Absentee ballots will be mailed out 22-29 days before the election. Completed ballots can be submitted via mail, in person, or at designated dropbox locations during early voting hours. For details, visit the Cherokee County Elections website. Commercial: And now here is Leah McGrath from Ingles Markets on sodas We’ll have closing comments after this.   COMMERCIAL: Ingles Markets 10   SIGN OFF –   Thanks again for hanging out with us on today’s Cherokee Tribune Ledger Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.tribuneledgernews.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com Etowah Mill #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

A recent opinion piece in the Wall Street Journal made a straightforward claim with its headline: “AI Is Learning to Escape Human Control.” The author, AE Studio CEO Judd Rosenblatt, cites reported incidents of artificial intelligence models disobeying orders to shut down and even blackmailing a human engineer. But others in the industry say Rosenblatt’s claim could needlessly spur panic among the public. For this edition of Feedback Friday on “Closer Look,” we ask listeners to share their questions and concerns about artificial intelligence. Host Rose Scott takes your calls alongside Emory University law professor Ifeoma Ajunwa, founding director of the AI and the Future of Work Program.See omnystudio.com/listener for privacy information.

Ilya Beylin, associate professor of law at Seton Hall University, joins the Business Scholarship Podcast to discuss his article Event Contracts Are a Step Too Far for Derivatives Regulation. This episode is hosted by Andrew Jennings, associate professor of law at Emory University, and was edited by Dean Saridakis, a law student at Emory University.

Respiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions.In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.Listen as they discuss:The Burden of Adult RSVRSV Vaccines for Adults: Data and RecommendationsRSV Vaccine UptakePractical Strategies to Increase RSV Vaccine Uptake Faculty:Dr. Ruth Carrico is a family nurse practitioner and senior consultant with Carrico & Ramirez, PLLC focused on infectious diseases, infection prevention and control, and vaccinology.  She is based in Louisville, Kentucky and is a Professor, adjunct faculty, with the University of Louisville School Medicine, Division of Infectious Diseases. Dr. Carrico has received training specific for healthcare epidemiology at the Centers for Disease Control and Prevention (CDC) in conjunction with the Rollins School of Public Health at Emory University in Atlanta and the Society for Healthcare Epidemiology of America (SHEA). Dr. Carrico has worked in the field of infectious diseases and infection control for more than thirty years.  Dr. Carrico also maintains a clinical practice focused on vaccines, vaccination, and immunization processes.Dr. Audrey M. Stevenson is a family nurse practitioner with over 40 years of clinical, public health, and leadership experience. Dr. Stevenson, who holds a master of public health and master of nursing degrees, received her doctorate in public health from the University of Utah. She formerly worked in public health for over 34 years and was the former Division Director of Family Health and Clinical Services of the Salt Lake County Health Department in Salt Lake City, Utah. She currently works as a consultant and teaches graduate FNP and MPH students at two universities. Dr. Stevenson is also a member of the statewide vaccine advisory board, where she collaborates on vaccine policies and recommendations for the state. Previously, Dr. Stevenson served as Vaccination Branch Director for the COVID-19 Incident Command for Salt Lake County, where she directed the vaccination strategies for 1.2 million residents of Salt Lake County. She has been a vaccine champion for over 30 years. Learn more:Download this practical infographic to help you integrate RSV vaccination into your clinical practice.https://bit.ly/43mzacqFor more information for nurses, subscribe to the PCE podcast channel on your favorite player! 

Respiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions.In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV.Listen as they discuss:The Burden of Adult RSVRSV Vaccines for Adults: Data and RecommendationsRSV Vaccine UptakePractical Strategies to Increase RSV Vaccine UptakeFaculty:Dr. Ruth Carrico is a family nurse practitioner and senior consultant with Carrico & Ramirez, PLLC focused on infectious diseases, infection prevention and control, and vaccinology.  She is based in Louisville, Kentucky and is a Professor, adjunct faculty, with the University of Louisville School Medicine, Division of Infectious Diseases. Dr. Carrico has received training specific for healthcare epidemiology at the Centers for Disease Control and Prevention (CDC) in conjunction with the Rollins School of Public Health at Emory University in Atlanta and the Society for Healthcare Epidemiology of America (SHEA). Dr. Carrico has worked in the field of infectious diseases and infection control for more than thirty years.  Dr. Carrico also maintains a clinical practice focused on vaccines, vaccination, and immunization processes.Dr. Audrey M. Stevenson is a family nurse practitioner with over 40 years of clinical, public health, and leadership experience. Dr. Stevenson, who holds a master of public health and master of nursing degrees, received her doctorate in public health from the University of Utah. She formerly worked in public health for over 34 years and was the former Division Director of Family Health and Clinical Services of the Salt Lake County Health Department in Salt Lake City, Utah. She currently works as a consultant and teaches graduate FNP and MPH students at two universities. Dr. Stevenson is also a member of the statewide vaccine advisory board, where she collaborates on vaccine policies and recommendations for the state. Previously, Dr. Stevenson served as Vaccination Branch Director for the COVID-19 Incident Command for Salt Lake County, where she directed the vaccination strategies for 1.2 million residents of Salt Lake County. She has been a vaccine champion for over 30 years. Learn more:Download this practical infographic to help you integrate RSV vaccination into your clinical practice.https://bit.ly/43mzacqFor more information for nurses, subscribe to the PCE podcast channel on your favorite player! 

Navigating Multiple Customer Segments, Needs, and Expectations  Shep interviews Ryan Hamilton, associate professor of marketing at Emory University's Goizueta Business School and co-host of The Intuitive Customer. He talks about his new book, The Growth Dilemma, and the challenges brands face in serving multiple customer segments with differing needs and expectations.   This episode of Amazing Business Radio with Shep Hyken answers the following questions and more:    How does customer segmentation impact how customer experiences are designed?  How can businesses navigate conflicts between different customer groups seeking unique experiences?  In what ways do ideological differences between customers influence brand experience?  Why is it important for companies to continually adapt their customer experience as their customer base grows?  How do influencers impact customer behavior?  Top Takeaways:    Some companies believe that they are only serving one type of customer. In reality, there are often several segments with different needs and expectations. Take Disney, for example. They serve both families with kids and “Disney adults”—grown-ups who love the Disney experience just as much. Each group may be looking for something different, but both are important to the overall customer experience.  Companies need to recognize how different customer groups impact the business and how they interact with one another. When companies do not understand the different customer segments that they serve, they risk accidentally leaving one group out (and losing their business) or even creating conflict between groups.  One way to keep different customer groups happy is to design experiences just for them, even if they are sharing the same space. Depending on your type of business, this could mean creating special areas, offering different products, or even building new locations with certain features in mind.   As a business grows, so will its customer base. This means adjusting and innovating to meet the diverse needs and expectations of their customers. Successful brands continually evolve to attract and serve new customers without compromising the identity that initially drew their original customers.  Innovation is a double-edged sword. It can bring about changes that improve or disrupt the customer experience. Brands need to be willing to listen to customer feedback and adapt accordingly. Good communication and flexibility show customers that their opinions matter.  Customer segments and expectations evolve. What works for a brand today might not work tomorrow. Brands need to continually monitor how their different customer segments change and interact with each other, and be ready to adjust products, services, and experiences to keep everyone happy.  Plus, Shep and Ryan discuss how influencer and follower relationships drive trends and customer behavior. Tune in!  Quote:    "Serving one customer segment is challenging enough, but when you have multiple groups wanting different things, you're managing a whole ecosystem where you need to keep each customer happy."  About:    Ryan Hamilton is a keynote speaker and an associate professor of marketing at Emory University's Goizueta Business School. He is the co-author of The Intuitive Customer and the co-host of a podcast with the same name. His new book, co-authored with Annie Wilson, The Growth Dilemma: Managing Your Brand When Different Customers Want Different Things, is now available on Amazon.    Shep Hyken is a customer service and experience expert, New York Times bestselling author, award-winning keynote speaker, and host of Amazing Business Radio.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Continuing our series on What You May Have Missed at ATS 2025, host Amy Attaway, MD, MS, of Cleveland Clinic, dives into key topics from the Clinical Year in Review with Sara Auld, MD, MSc, Emory University. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package. 

Send us a textBedwetting is incredibly common—but it's also often misunderstood, leaving families feeling frustrated, confused, or even ashamed. In this episode, pediatric urologist Dr. Andrew Kirsch joins Dr. Jessica Hochman to demystify nighttime wetting and offer real, evidence-based guidance for parents.They explore:Why bedwetting happens (hint: it's not your child's fault)When to worry and when to waitThe truth about bedwetting alarms and medicationsA promising new non-drug device called Solu that could reshape how we treat bedwettingWhether you're in the thick of it with your child or just want to be prepared, this episode offers clarity, compassion, and plenty of practical tips.Dr. Andrew Kirsch is a board-certified pediatric urologist with over 25 years of experience. He serves as Chief of Pediatric Urology at Emory University and Children's Healthcare of Atlanta, one of the nation's largest pediatric healthcare systems. He's also the co-author of The Ultimate Bedwetting Survival Guide and co-founder of Global Continence, a company developing innovative, non-invasive solutions for childhood bedwetting.Dr Jessica Hochman is a board certified pediatrician, mom to three children, and she is very passionate about the health and well being of children. Most of her educational videos are targeted towards general pediatric topics and presented in an easy to understand manner. For more content from Dr Jessica Hochman:Instagram: @AskDrJessicaYouTube channel: Ask Dr JessicaWebsite: www.askdrjessicamd.com-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA Do you have a future topic you'd like Dr Jessica Hochman to discuss? Email Dr Jessica Hochman askdrjessicamd@gmail.com.The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditions or formulate treatment plans for specific individuals. If you have a concern about your child's health, be sure to call your child's health care provider.

Dr. Steffany Moonaz is a yoga therapist and researcher in Southern California. She serves as Research Director at Southern California University of Health Sciences and Professor at the Maryland University of Integrative Health. She became curious about the importance of mind-body activities at a young age and has always had a passion and a curiosity about the healing power of mindful movement. She completed undergraduate work in biology and dance at Oberlin College, earned an MFA from University of Maryland as well as a CMA from the Laban Institute and spent eight years at Johns Hopkins University, helping to develop and evaluate a yoga program for individuals with the chronic diseases of rheumatoid arthritis and osteoarthritis, which became the basis for her PhD in public health.Along with ongoing research collaborations with major research institutions worldwide, Dr. Moonaz is working to bring yoga to people with arthritis directly, as well as educating yoga teachers and yoga therapists about the unique needs of this population. She currently leads Yoga for Arthritis teacher training programs and serves as a mentor for several emerging researchers who are working to study the effects of yoga for various health conditions. Dr. Moonaz also serves on the faculty of several other yoga and yoga therapy training programs, including Integral Yoga, Phoenix Rising, and The Mindfulness Center.Dr. Moonaz's work has been covered by Time, HuffPost, the Baltimore Sun, and U.S. News and World Report. She has been invited to speak at Emory University, Brigham and Women's Hospital, Johns Hopkins Palliative Care, and the Smithsonian. Her Arthritis-Friendly Yoga DVD, produced by the Arthritis Foundation, became their best-selling product when it was released in 2013. Her first book, Yoga Therapy for Arthritis: A whole-person approach to movement and lifestyle, was published by Singing Dragon Publishers in December of 2018, and she has contributed to several other widely used yoga texts. Her second book, Driving Home, a memoir, was released in 2024 by Freisen Press and shares an unforgettable year of identity, responsibility, and the unexpected lessons of adversity. Steffany's Website: https://www.arthritis.yoga/Steffany's Instagram: @yogaforarthritisSupport the show

Learning Objectives:By the end of this series, listeners should be able to discuss:The physiologic rationale supporting the use of airway pressure release ventilation (APRV) in ARDS. The patient populations most likely to benefit from APRV.Key published evidence that informs our use of APRV in critical care.An expert approach to managing a patient with APRV.Next steps in research that will direct our understanding of the use of APRV in pediatric critical care.About our Guest: Dr. Palen Mallory is an assistant professor of pediatrics at Duke University and a pediatric intensivist at Duke Children's Hospital. She completed medical school at Virginia Commonwealth University, a pediatric residency at Emory University, and a critical care fellowship at Vanderbilt University. She is interested in respiratory care research, including ECMO, respiratory failure, and ARDS.Selected References:Mallory, P., & Cheifetz, I. (2020). A comprehensive review of the use and understanding of airway pressure release ventilation. Expert Review of Respiratory Medicine, 14(3), 307–315. https://doi.org/10.1080/17476348.2020.1708719Frawley, P. M., & Habashi, N. M. (2004). Airway pressure release ventilation and pediatrics: Theory and practice. Critical Care Nursing Clinics of North America, 16(3 SPEC. ISS.), 337–348. https://doi.org/10.1016/J.CCELL.2004.04.003Fredericks, A. S., Bunker, M. P., Gliga, L. A., Ebeling, C. G., Ringqvist, J. R. B., Heravi, H., Manley, J., Valladares, J., & Romito, B. T. (2020). Airway Pressure Release Ventilation: A Review of the Evidence, Theoretical Benefits, and Alternative Titration Strategies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 14. https://doi.org/10.1177/1179548420903297APRV Guideline - EMCrit Project. (n.d.). Retrieved March 30, 2025, from https://emcrit.org/squirt/aprv/Andrews P, Shiber J, Madden M, Nieman GF, Camporota L, Habashi NM. Myths and Misconceptions of Airway Pressure Release Ventilation: Getting Past the Noise and on to the Signal. Front Physiol. 2022 Jul 25;13:928562. doi: 10.3389/fphys.2022.928562. PMID: 35957Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

Have you ever said “thank you” to a chatbot or Chat GPT? Well, you're not alone—and you might just be weirder than you think. It turns out AI can be more empathic than people. But what do Customers think of AI experiences? Academic research reveals the answers we discuss in this show.  In this special live-recorded episode from the SOCAP Conference, Colin Shaw and Professor Ryan Hamilton explore the psychology behind how customers actually feel about AI—and what that means for your customer experience. Ryan dives into the latest academic research on AI trust, customer behaviour, and why people treat AI like it's part of the cast of Friends. Meanwhile, Colin keeps things grounded with real-life examples with his usual “so what?” test. What You'll Learn in This Episode: Why 50% of customers trust companies less when they know AI is involved How AI literacy backfires (the more people understand it, the less they use it!) The subtle “outgroup” bias customers apply to AI systems Why hedonic recommendations (like chocolate) must come from humans How one bad AI interaction can poison the well for all future ones What the hell “personification” means—and why it matters for your brand The surprising emotional tension behind AI adoption (it's empowering and scary) Best Quote from the Episode: “AI isn't human, but customers treat it like it is—and that means it's being judged by human standards. If it screws up once, they'll remember. And they'll blame all AI for it.” – Professor Ryan Hamilton Resources Mentioned This podcast is sponsored by SOCAP International and IA Solutions, who are both as passionate about improving customer experience as we are. SOCAP: https://socap.org/ IA Solutions: https://iacallcenter.com/  Research References: Castelo, Noah, Maarten W. Bos, and Donald R. Lehmann (2019), “Task-Dependent Algorithm Aversion,” Journal of Marketing Research, 56 (5), 809-825. Dietvorst, Berkeley J., Joseph P. Simmons, and Cade Massey (2015), “Algorithm aversion: people erroneously avoid algorithms after seeing them err,” Journal of Experimental Psychology: General, 144, 1, 114. Hermann, Erik, and Stefano Puntoni, (2024), “Artificial intelligence and consumer behavior: From predictive to generative AI,” Journal of Business Research, 180, 114720. Ipsos (2022), “Global opinions about AI – January 2022, https://t.ly/qyyEI Longoni, Chiara, and Luca Cian (2022), “Artificial Intelligence in Utilitarian vs. Hedonic Contexts: The “Word-of-Machine” Effect,” Journal of Marketing, 86 (1), 91-108. Puntoni, Stefano, Rebecca W. Reczek, Markus Giesler, and Simona Botti (2021), “Consumers and Artificial Intelligence: An Experiential Perspective,” Journal of Marketing, 85 (1), 131-151. Santoro, Erik, and Benoît Monin (2023), “The AI Effect: People rate distinctively human attributes as more essential to being human after learning about artificial intelligence advances,” Journal of Experimental Social Psychology 107, 104464. About the Hosts: Colin Shaw is a LinkedIn 'Top Voice' with a massive 284,000 followers and 86,000 subscribers to his 'Why Customers Buy' newsletter. Shaw is named one of the world's 'Top 150 Business Influencers' by LinkedIn. His company, Beyond Philosophy LLC, has been selected four times by the Financial Times as a top management consultancy. Shaw is co-host of the top 1.5% podcast 'The Intuitive Customer'—with over 600,000 downloads—and author of eight best-sellers on customer experience, Shaw is a sought-after keynote speaker. Follow Colin on LinkedIn. Ryan Hamilton is a Professor of Marketing at Emory University's Goizueta Business School and co-author of 'The Intuitive Customer' book. An award-winning teacher and researcher in consumer psychology, he has been named one of Poets & Quants' "World's Best 40 B-School Profs Under 40." His research focuses on how brands, prices, and choice architecture influence shopper decision-making, and his findings have been published in top academic journals and covered by major media outlets like The New York Times and CNN. His work highlights how psychology can help firms better understand and serve their customers. Ryan has a new book launch in June 2025 called “The Growth Dilemma: Managing Your Brand When Different Customers Want Different Things” Harvard Business Press Follow Ryan on LinkedIn.   Subscribe & Follow   Apple Podcasts Spotify

Ingen kunde som Jayne County blanda glammig rock med burlesk, crossdressing, fulmejk och texter med sexuellt laddat innehåll. Lyssna på alla avsnitt i Sveriges Radio Play. Jayne County banade väg och fick en hel del andra artister att våga ta ut svängarna under den begynnande glamrockeran. David Bowie var en av dem som lät sig inspireras. Pete Burns i Dead or Alive var en annan.Jayne County säger att ett av hennes mål var att starta ett band skulle vara chockerande och upprörande. ”Jag ville få Alice Cooper att framstå som en nunna”, som hon säger. Det kan man lugn påstå att hon lyckades med.Hon kunde uppträda i en klänning tillverkad av uppblåsta kondomer och hade på sin repertoar låtar med titlar som: Stick It in Me, Fucked by the Devil, Prostitute with a Parachute och många, många fler på liknande tema.Det är förstås en av anledningarna till att Jayne County inte fick någon radiohit och aldrig nådde fram till den riktigt stora och breda publiken. Men idag betraktas hon, med all rätt, som en pionjär, en banbrytare och en levande legend.I veckans program pratar vi med Petter Wallenberg, artist, författare och grundare av dragteatersällskapet Bland drakar och dragqueens. Han har länge sett upp till Jayne County. Vi pratar också med curatorn Daniel Fuller som nyligen ställde ut Jayne Countys konst på The Emory Visual Arts Gallery – ett konstgalleri som hör till ansedda Emory University i Atlanta. Och så tar vi en titt på en samtida transpionjär: supermodellen Alex Consani.

From Training to Practice is a monthly podcast that explores the often-overlooked, high-stakes transition from radiology trainee to new attending. Hosted by Dr. Surbhi Raichandani, an abdominal radiologist at Emory University, this 12-part series blends personal reflection with honest conversations featuring radiologists, physicians, and healthcare experts who have lived it. Each episode tackles a real challenge faced in the first year of independent practice—whether it's building confidence, navigating new systems and expectations, staying efficient without burning out, or figuring out how to lead when you still feel like you're learning. This podcast is designed for early-career radiologists, fellows approaching graduation, and anyone who remembers what that leap felt like.

You can text us here with any comments, questions, or thoughts!In this episode, Kemi welcomes Dr. Adesuwa Akhetuamhen, an emergency medicine physician and faculty member at Emory University. Dr. Akhetuamhen's research focuses on preventative medicine for emergency department patients at risk for neuro-cardiovascular disease. She has substantial experience in clinical medicine, with specialized training and expertise in addressing racial health disparities, conducting medical education research, and neuro-cardiovascular disease prevention in emergency care settings. Tune in as they discuss Adesuwa's experience with the Get That Grant® program, she reflects on the importance of community, mentorship, and the actionable strategies that have propelled her career forward. Adesuwa's candid insights reveal how she navigated the challenges of motherhood while achieving significant milestones, including securing her first grant shortly after completing the program. Conversation Highlights: The importance of community in academia Navigating motherhood and career milestones Overcoming challenges and celebrating wins The power of passion in research If Adesuwa's story resonated with you - and you're looking for structured support, community, and strategy in your own academic journey - now's the time to take the next step.  Applications are now open for the July 2025 cohort of Get That Grant®. Apply here. P.S. New this round: We're piloting direct institutional payments - and this is the last time GTG® will be offered at its current price. Loved this convo? Please go find Dr. Akhetuamhen on LinkedIn and Instagram (@adeakhmd) to show her some love!  And if you'd like to learn more foundational career navigation concepts for women of color in academic medicine and public health, sign up for our KD Coaching Foundations Series: www.kemidoll.com/foundations. REMINDER: Your Unapologetic Career Podcast now releases episode every other week! Can't wait that long? Be sure you are signed up for our newsletter (above) where there are NEW issues every month! 

Ian Sample meets Jaap de Roode, professor of biology at Emory University in Atlanta, and author of the book Doctors by Nature: How Ants, Apes and Other Animals Heal Themselves. De Roode explains how a chance discovery got him interested in animal medicine, the amazing ways that creatures use toxins to fight parasites and pathogens, and what humans have learnt about medicine from the animal world. Help support our independent journalism at theguardian.com/sciencepod

In this episode Eric interviews Nadine Kaslow from Emory University and Grady Memorial Hospital in Atlanta, GA. Nadine discusses her work schedule, including her teaching responsibilities, research, and administrative duties. She also shares her strategies for balancing an extensive workload, highlighting the importance of efficiency, good systems, and collaborative teamwork. The conversation delves into her approach to self-care, the impact of COVID-19 on her professional and personal practices, and her thoughts on the future challenges and opportunities for the field of psychology. She reflects on her experiences growing up with a psychologist mother, her academic journey, and her tenure as President of the American Psychological Association. The discussion concludes with valuable advice for students and professionals on the importance of following one's passions and maintaining a sense of meaning and purpose in their work. [Note. Portions of the show notes were generated by Descript AI.]

What if the key to better cancer outcomes lies not just in surgery or chemotherapy, but also in mindfulness, movement, and diet? In this episode of the BackTable Tumor Board, host Dr. Aditya Bagrodia interviews urologic oncologist Dr. Viraj Master, Professor of Urology at Emory University, about his role in developing the integrative oncology and survivorship service line at Winship Cancer Institute. --- This podcast is supported by: Ferring Pharmaceuticals https://ad.doubleclick.net/ddm/trackclk/N2165306.5658203BACKTABLE/B33008413.420220578;dc_trk_aid=612466359;dc_trk_cid=234162109;dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_755};gpp=${GPP_STRING_755};gpp_sid=${GPP_SID};ltd=;dc_tdv=1 --- SYNPOSIS They discuss the evidence-based use of complementary therapies alongside conventional cancer treatments, touching on various integrative methods including diet, exercise, mindfulness, acupuncture, yoga, and supplements. Dr. Master emphasizes the importance of physicians being open to these practices and understanding their potential benefits for improving patient outcomes and quality of life, even in highly acute cases like muscle-invasive bladder cancer. The conversation covers the importance of honesty and understanding across patient journeys–from initial diagnosis to survivorship–highlighting the value of holistic approaches in cancer care. ---TIMESTAMPS00:00 - Integrative Oncology: Definitions and Basics06:28 - Exercise and Its Impact on Cancer Treatment08:12 - Physician Perspectives on Complementary Medicine20:58 - Acupuncture and Acupressure in Cancer Care25:28 - Practical Implementation of Integrative Approaches31:30 - Supplements and Immuno Nutrition36:25 - Cannabis, CBD, and Ayurveda in Cancer Care44:39 - Conclusion and Final Thoughts --- RESOURCES Society of Urologic Oncologyhttps://suonet.org/home.aspx

Sara Pirkle is a Southern poet, an identical twin, a breast cancer survivor, and a board game enthusiast. Her first full-length collection of poetry, The Disappearing Act, won the Adrienne Bond Award for Poetry and was published by Mercer University Press in 2018. In 2019, she was nominated for Georgia Author of the Year in Poetry, and in 2022 she was shortlisted for the Oxford Poetry Prize. She also dabbles in songwriting and co-wrote a song on Remy Le Boeuf's album, Architecture of Storms, which was nominated for a 2023 GRAMMY in the Best Large Jazz Ensemble Album category. Pirkle's poems have been nominated for the Pushcart Prize five times, the Best of the Net Anthology twice, and the Independent Best American Poetry Award. She earned a PhD in English from Georgia State University and an MFA in Creative Writing from Georgia College & State University. She is an Associate Director of Creative Writing at The University of Alabama.Anya Krugovoy Silver was born in Media, Pennsylvania in December of 1968, and she grew up in Swarthmore. The child of immigrants, her first two languages were German and Russian. She graduated from Haverford College, and she earned a PhD in literature from Emory University in Atlanta. In 1998, Silver and her husband began teaching at Mercer University in Macon, Georgia. While pregnant with their son in 2004, she was diagnosed with and treated for inflammatory breast cancer. After five years of remission, her cancer returned as bone metastasis in 2010. She published four books of poetry and one book of criticism in her lifetime. She won the Georgia Author of the Year Award in 2015, and she was awarded a Guggenheim Fellow for Poetry in 2018, the same year in which she died. At the time of her death, she was in the process of editing her fifth book, Saint Agnostica, which was published in 2021 by Louisiana State University Press. The following poems were recorded with permission from Louisiana State University Press: Silver, Anya Krugovoy. “Blush” and “The Poem in My Childhood.” The Ninety-Third Name of God: Poems, Louisiana State University Press, 2010Silver, Anya Krugovoy. “There's a River.” I Watched You Disappear: Poems, Louisiana State University Press, 2014Silver, Anya Krugovoy. “From Nothing.” From Nothing: Poems, Louisiana State University Press, 2016Silver, Anya Krugovoy. “Being Ill.” Saint Agnostica: Poems, Louisiana State University Press, 2021Links: Sara PirkleSara Pirkle's website"Weighing the Options" in Delta Poetry Review"Not Prometheus" in Eclectica"Pretend You Don't Owe Me a Thing" in Rattle"Evolution of the Writing Process: A Conversation with Dr. Sara Pirkle Hughes"--University of AlabamaAnya Krugovoy SilverBio and poems at The Poetry Foundation"Anya Krugovoy Silver, 1968-1018" in New Georgia Encyclopedia

Sara Pirkle is a Southern poet, an identical twin, a breast cancer survivor, and a board game enthusiast. Her first full-length collection of poetry, The Disappearing Act, won the Adrienne Bond Award for Poetry and was published by Mercer University Press in 2018. In 2019, she was nominated for Georgia Author of the Year in Poetry, and in 2022 she was shortlisted for the Oxford Poetry Prize. She also dabbles in songwriting and co-wrote a song on Remy Le Boeuf's album, Architecture of Storms, which was nominated for a 2023 GRAMMY in the Best Large Jazz Ensemble Album category. Pirkle's poems have been nominated for the Pushcart Prize five times, the Best of the Net Anthology twice, and the Independent Best American Poetry Award. She earned a PhD in English from Georgia State University and an MFA in Creative Writing from Georgia College & State University. She is an Associate Director of Creative Writing at The University of Alabama.Anya Krugovoy Silver was born in Media, Pennsylvania in December of 1968, and she grew up in Swarthmore. The child of immigrants, her first two languages were German and Russian. She graduated from Haverford College, and she earned a PhD in literature from Emory University in Atlanta. In 1998, Silver and her husband began teaching at Mercer University in Macon, Georgia. While pregnant with their son in 2004, she was diagnosed with and treated for inflammatory breast cancer. After five years of remission, her cancer returned as bone metastasis in 2010. She published four books of poetry and one book of criticism in her lifetime. She won the Georgia Author of the Year Award in 2015, and she was awarded a Guggenheim Fellow for Poetry in 2018, the same year in which she died. At the time of her death, she was in the process of editing her fifth book, Saint Agnostica, which was published in 2021 by Louisiana State University Press. The following poems were recorded with permission from Louisiana State University Press: Silver, Anya Krugovoy. “Blush” and “The Poem in My Childhood.” The Ninety-Third Name of God: Poems, Louisiana State University Press, 2010Silver, Anya Krugovoy. “There's a River.” I Watched You Disappear: Poems, Louisiana State University Press, 2014Silver, Anya Krugovoy. “From Nothing.” From Nothing: Poems, Louisiana State University Press, 2016Silver, Anya Krugovoy. “Being Ill.” Saint Agnostica: Poems, Louisiana State University Press, 2021Links: Sara PirkleSara Pirkle's website"Weighing the Options" in Delta Poetry Review"Not Prometheus" in Eclectica"Pretend You Don't Owe Me a Thing" in Rattle"Evolution of the Writing Process: A Conversation with Dr. Sara Pirkle Hughes"--University of AlabamaAnya Krugovoy SilverBio and poems at The Poetry Foundation"Anya Krugovoy Silver, 1968-1018" in New Georgia Encyclopedia

Our guest speaker for the 2025 Annual Conference is Rev. F. Douglas Powe, Jr., PhD. In this episode, we learn more about him, and what he will share with us during his time at Annual Conference. Learn more about how it's time to re-examine John Wesley's model of evangelism as a full, natural circle, where it's a communal beginning point rather than a solitary end.   Dr. Powe is the President of Phillips Theological Seminary. Powe comes to Phillips from Wesley Theological Seminary, where he served as director of The Lewis Center for Church Leadership and the James C. Logan Chair in Evangelism (an E. Stanley Jones Professorship). Powe is an ordained elder in the Baltimore/Washington Annual Conference of the United Methodist Church. He received his BA from Ohio Wesleyan University in 1987, his MDiv from Candler School of Theology at Emory University in 1998, and his PhD from Emory University in 2004. Books: Transforming Evangelism: The Wesleyan Way of Sharing Faith Sustaining While Disrupting: The Challenge of Congregational Innovation

Dany Hernandez is a Cuban immigrant pursuing his passion for connection and community through technology and business. He graduated from Emory University in 2023 with a focus on Marketing, Entrepreneurship, and Organization & Management. He’s working on a startup called Sonaara, a meetup app that connects users to one another at local spots, creating authentic, […] The post Dany Hernandez With Sonaara appeared first on Business RadioX ®.

Are we focusing too much on body structures and functions?   Should participation and the F-words—Fun, Family, Friends, Fitness, Function, and Future—be leading the way?  Dr. Ginny Paleg is a pediatric physiotherapist specializing in children with severe motor impairments, particularly those at GMFCS Levels IV and V. She holds a Master's in Physical Therapy from Emory University and a Doctorate from the University of Maryland Baltimore.   Certified in the Prechtl GMA and HINE, Dr. Paleg integrates evidence-based tools with coaching and routines-based interventions. With over 60 peer-reviewed publications, her research spans standers, supported stepping, and power mobility for children with complex needs. She is the lead author of the AACPDM Hypotonia Care Pathway and serves on the AACPDM Care Pathway Council, having held key roles in both AACPDM and the EACD.  If you've ever found yourself in a heated Facebook thread or a passionate discussion with colleagues about what really matters in pediatric therapy, you're not alone. Dr. Ginny Paleg moderates some of these spaces, and what's always clear is that therapists deeply care—they want children to thrive. But the differences in approach can be striking.   Today, we're diving into the heart of this tension through the lens of the ICF-CY framework. It's a big conversation, and one we think is absolutely worth having.

The Trump administration is moving quickly to increase its deportation numbers and further expand its restrictions on immigration. But federal judges are continuing to rule against the president on immigration matters. White House correspondent Laura Barrón-López discussed the legal battles with Charles Kuck, an Atlanta-based immigration attorney and law professor at Emory University. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Bruce's guest today is Dr. Luther E. Smith Jr. Luther is Professor Emeritus of Church and Community, Candler School of Theology, Emory University, and is the author and editor of influential books on Howard Thurman, Christian community, and spiritual practices. Luther and Henri Nouwen Society ED Bruce Adema discuss a letter Henri Nouwen wrote to his friend Sue Mosteller about his concerns, even apprehensions about the future. This topic will surely resonate with everyone, and provide encouragement. ___________ Book Discussed: Love, Henri https://amzn.to/3fpnolF (US) https://amzn.to/2C2lqcD (Canada) The Wounded Healer https://amzn.to/2AGOrKz (US) https://amzn.to/3hdDkcr (Canada) ___________ SUPPORT THIS PODCAST: henrinouwen.org/donate/ * SIGN UP FOR FREE DAILY E-MEDITATIONS: henrinouwen.org/meditation/ * MORE FREE RESOURCES: henrinouwen.org/ * FOLLOW US ON SOCIAL MEDIA: INSTAGRAM: www.instagram.com/henrinouwensociety/ TWITTER: twitter.com/nouwensociety FACEBOOK: www.facebook.com/nouwensociety/ PINTEREST: www.pinterest.ca/henrinouwen/

Navigating the Growth Dilemma with Ryan Hamilton   Welcome to the What's Next! Podcast with Tiffani Bova.    I'm thrilled to welcome Ryan Hamilton to the show this week. Ryan is an associate professor of marketing at Emory University's Goizueta Business School. He has consulted on branding with Walmart, FedEx, Home Depot, Caterpillar, ConAgra, Cigna, Visa, and Ipsos, among others, and has been a keynote speaker. He cohosts a podcast, called The Intuitive Customer, which applies the insights of behavioral science to customer experience. He has produced lecture series on both marketing and human decision making for The Great Courses. He is the co-author of a new book, The Growth Dilemma.    THIS EPISODE IS PERFECT FOR…anyone navigating brand growth and customer strategy decisions across evolving markets and customer segments.   TODAY'S MAIN MESSAGE…growth is a natural goal for businesses, but attracting new customers can unintentionally alienate the ones you already have. Ryan calls this the growth dilemma. As you expand your customer base, you risk creating conflicts between different groups of customers, conflicts that can undermine your success. Ryan outlines four kinds of customer conflict and how businesses can better anticipate and manage them before making big moves.   KEY TAKEAWAYS: Growth can backfire if you don't manage customer conflicts Start by maximizing value from existing customers before chasing new ones The four common conflict types are functional, brand image, user identity, and ideological   WHAT I LOVE MOST…Ryan's insight that brands often chase new customers without realizing the conflicts it creates, when the gold might already be in their existing customer base.   Running Time: 27:02    Subscribe on iTunes     Find Tiffani Online: LinkedIn Facebook X    Find Ryan Online: LinkedIn   Ryan & Annie's Book: The Growth Dilemma: Managing Your Brand When Different Customers Want Different Things

Show Notes:We hear a lot about the rapid decline in church attendance across the country, but there are many churches who are experiencing growth. So what, exactly, are these churches doing to attract new members? Matt Miofisky has a few ideas.Matt is the founder of The Gathering, a multi-site United Methodist congregation in St. Louis, Missouri. As the founder and leader of a consistently growing urban church and the co-author of Eight Virtues of Rapidly Growing Churches, Matt is more than qualified for today's conversation.Matt is a graduate of Washington University in St. Louis, where he majored in mathematics before earning his Master's of Divinity at Emory University. He founded The Gathering in 2006, which was recently named the third fastest growing large United Methodist church in the US.Resources:Learn more about The Gathering hereBuy Eight Virtues of Rapidly Growing Churches hereBuy The Methodist Book of Daily Prayer hereBuy Matt's other books hereListen to The F Word, Matt's podcast on Spotify or Apple PodcastsFollow Matt on Instagram or Facebook

Michael S. Lloyd, MD, FHRS, Emory University is joined by Edward P. Gerstenfeld, MD, MS, FHRS, University of California, San Francisco, and Christopher C Cheung, MD, MPH, FHRS, Sunnybrook HSC, University of Toronto, to discuss the VOLT-AF IDE study evaluated the safety and effectiveness of a novel balloon-based pulsed field ablation (PFA) catheter system for treating paroxysmal and persistent atrial fibrillation (PAF and PsAF). Conducted at 34 global sites, the study enrolled 394 subjects, with 320 included in the primary analysis. Acute pulmonary vein isolation (PVI) success was achieved in over 99% of veins, and primary serious adverse events occurred in only 1.9% of patients, with no significant complications like esophageal injury or hemolysis. Procedure metrics showed efficient operation times, and early 6-month data suggest promising effectiveness. These initial findings support the Volt™ PFA system as a safe and effective treatment option for AF.    https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)02168-X/fulltext Host Disclosure(s): M. Lloyd: Honoraria/Speaking/Consulting: Medtronic, Arga Medtech, Circa Scientific Membership on Advisory Committees: Boston Scientific Contributor Disclosure(s):   E. Gerstenfeld: Honoraria/Speaking/Consulting: Medtronic, Boston Scientific, Biosense Webster, Abbott, Varian Medical Systems, Biotronik Other Non-Financial Relationships: Farapulse, Adagio Medical, Boston Scientific, Abbott Medical, Research (Contracted Grants for PIs and Named Investigators only): Abbott Medical Officer, Trustee, Director, Committee Chair, or Any Other Fiduciary Role: American College of Cardiology Foundation C. Cheung: Nothing to disclose.

The Trump administration is moving quickly to increase its deportation numbers and further expand its restrictions on immigration. But federal judges are continuing to rule against the president on immigration matters. White House correspondent Laura Barrón-López discussed the legal battles with Charles Kuck, an Atlanta-based immigration attorney and law professor at Emory University. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Ages before the dawn of modern medicine, wild animals were harnessing the power of nature's pharmacy to heal themselves. Doctors by Nature: How Ants, Apes, and Other Animals Heal Themselves (Princeton University Press, 2025) reveals what researchers are now learning about the medical wonders of the animal world. In this visionary book, Jaap de Roode argues that we have underestimated the healing potential of nature for too long and shows how the study of self-medicating animals could impact the practice of human medicine. Drawing on illuminating interviews with leading scientists from around the globe as well as his own pioneering research on monarch butterflies, de Roode demonstrates how animals of all kinds--from ants to apes, from bees to bears, and from cats to caterpillars--use various forms of medicine to treat their own ailments and those of their relatives. We meet apes that swallow leaves to dislodge worms, sparrows that use cigarette butts to repel parasites, and bees that incorporate sticky resin into their hives to combat pathogens. De Roode asks whether these astonishing behaviors are learned or innate and explains why, now more than ever, we need to apply the lessons from medicating animals--it can pave the way for healthier livestock, more sustainable habitats for wild pollinators, and a host of other benefits. Doctors by Nature takes readers into a realm often thought to be the exclusive domain of humans, exploring how scientists are turning to the medical knowledge of the animal kingdom to improve agriculture, create better lives for our pets, and develop new pharmaceutical drugs. Jaap de Roode is Samuel Candler Dobbs Professor of Biology at Emory University, where he is director of the Infectious Diseases across Scales Training Program, which trains graduate students in interdisciplinary science to study and control infectious disease. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/environmental-studies

Ages before the dawn of modern medicine, wild animals were harnessing the power of nature's pharmacy to heal themselves. Doctors by Nature: How Ants, Apes, and Other Animals Heal Themselves (Princeton University Press, 2025) reveals what researchers are now learning about the medical wonders of the animal world. In this visionary book, Jaap de Roode argues that we have underestimated the healing potential of nature for too long and shows how the study of self-medicating animals could impact the practice of human medicine. Drawing on illuminating interviews with leading scientists from around the globe as well as his own pioneering research on monarch butterflies, de Roode demonstrates how animals of all kinds--from ants to apes, from bees to bears, and from cats to caterpillars--use various forms of medicine to treat their own ailments and those of their relatives. We meet apes that swallow leaves to dislodge worms, sparrows that use cigarette butts to repel parasites, and bees that incorporate sticky resin into their hives to combat pathogens. De Roode asks whether these astonishing behaviors are learned or innate and explains why, now more than ever, we need to apply the lessons from medicating animals--it can pave the way for healthier livestock, more sustainable habitats for wild pollinators, and a host of other benefits. Doctors by Nature takes readers into a realm often thought to be the exclusive domain of humans, exploring how scientists are turning to the medical knowledge of the animal kingdom to improve agriculture, create better lives for our pets, and develop new pharmaceutical drugs. Jaap de Roode is Samuel Candler Dobbs Professor of Biology at Emory University, where he is director of the Infectious Diseases across Scales Training Program, which trains graduate students in interdisciplinary science to study and control infectious disease. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science

Today I'm delighted to welcome back David Mizejewski, a Naturalist & self-confessed Nature Geek who works for the National Wildlife Federation. David joined me for an inspiring discussion about leaving the leaves & Autumn tips for nature friendly gardening in Ep. 52. This time we're embracing Garden For Wildlife month & No Mow May, with tips for encouraging wildlife to thrive in your yard in Spring & Summer as well as sharing how container gardening can ensure that even in the smallest of outdoor spaces you can help contribute to supporting & nurturing your native flora & fauna.David is celebrating 25 years with NWF so alongside sharing his wonderful gardening tips our discussion draws on his experience to explore the sometimes unexpected value that urban spaces provide to nurture wildlife, the relationship between environmental & social justice issues & the power of community led nature spaces to create lasting change. We also share the fun we both had setting up wildlife cameras to spy on the new wild neighbours that move in when we create habitats in which they can thrive.In these dark & challenging times we our reminded that nature can be our sanctuary, providing joy & hope, when we share our spaces with amazing creatures & we welcome them into our lives we are rewarded in a myriad of unexpected ways.David Mizejewski is a naturalist, author & television presenter with the National Wildlife Federation. He holds a degree in Human & Natural Ecology from Emory University & is an expert on wildlife & our environment. He is dedicated to using his knowledge & unbridled enthusiasm to help others understand & protect the natural world. David regularly appears in the media to promote wildlife conservation.Website: https://naturalist.nwf.org/May is Garden for Wildlife® Month, the perfect time to celebrate your own garden & it's amazing impact on wildlife. From small balconies to spacious yards, wildlife gardens can have a big impact no matter their size! This year we're excited to celebrate gardens of all sizes & even gardens in unlikely locations! If you have an outdoor space such as a balcony, a flight of stairs up a brownstone, or even a small greenspace around a mailbox, you can garden for wildlife. Plus, if you sign up for the NWF Garden Habitats Newsletter in May, you can even be entered to win a native plant container garden bundle! With over seven million participants and over 50 years of service, Garden for Wildlife is America's largest, longest running habitat movement dedicated to helping wildlife thrive where people live, work, play, learn, & worship. Join over 315,000 Certified Wildlife Habitats® when you get your garden certified!https://www.nwf.org/Native-Plant-Habitats/Join-the-Movement/Seasonal-Initiatives/Garden-for-Wildlife-Monthhttps://www.nwf.org/gardenSupport the showThank you for being part of this journey with me, please Subscribe so you don't miss our future episodes, leave a review & share with friends to help these messages ripple out across the world. More information about the Podcast & our host Fiona MacKay: Fiona Mackay Photography WebsiteConnect with us & join the conversation on social media:Instagram @FionaMacKayPhotographyFacebook @FionaMacKayPhotographyTwitter @FiMacKay

Ages before the dawn of modern medicine, wild animals were harnessing the power of nature's pharmacy to heal themselves. Doctors by Nature: How Ants, Apes, and Other Animals Heal Themselves (Princeton University Press, 2025) reveals what researchers are now learning about the medical wonders of the animal world. In this visionary book, Jaap de Roode argues that we have underestimated the healing potential of nature for too long and shows how the study of self-medicating animals could impact the practice of human medicine. Drawing on illuminating interviews with leading scientists from around the globe as well as his own pioneering research on monarch butterflies, de Roode demonstrates how animals of all kinds--from ants to apes, from bees to bears, and from cats to caterpillars--use various forms of medicine to treat their own ailments and those of their relatives. We meet apes that swallow leaves to dislodge worms, sparrows that use cigarette butts to repel parasites, and bees that incorporate sticky resin into their hives to combat pathogens. De Roode asks whether these astonishing behaviors are learned or innate and explains why, now more than ever, we need to apply the lessons from medicating animals--it can pave the way for healthier livestock, more sustainable habitats for wild pollinators, and a host of other benefits. Doctors by Nature takes readers into a realm often thought to be the exclusive domain of humans, exploring how scientists are turning to the medical knowledge of the animal kingdom to improve agriculture, create better lives for our pets, and develop new pharmaceutical drugs. Jaap de Roode is Samuel Candler Dobbs Professor of Biology at Emory University, where he is director of the Infectious Diseases across Scales Training Program, which trains graduate students in interdisciplinary science to study and control infectious disease. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Judge blasts "unorgainzed" prosecution in "Stop Cop City" RICO action; Georgia Power pitches plan for making enough electricity for future demand; and a big change is coming to Emory University's top leadership. See omnystudio.com/listener for privacy information.

Ages before the dawn of modern medicine, wild animals were harnessing the power of nature's pharmacy to heal themselves. Doctors by Nature: How Ants, Apes, and Other Animals Heal Themselves (Princeton University Press, 2025) reveals what researchers are now learning about the medical wonders of the animal world. In this visionary book, Jaap de Roode argues that we have underestimated the healing potential of nature for too long and shows how the study of self-medicating animals could impact the practice of human medicine. Drawing on illuminating interviews with leading scientists from around the globe as well as his own pioneering research on monarch butterflies, de Roode demonstrates how animals of all kinds--from ants to apes, from bees to bears, and from cats to caterpillars--use various forms of medicine to treat their own ailments and those of their relatives. We meet apes that swallow leaves to dislodge worms, sparrows that use cigarette butts to repel parasites, and bees that incorporate sticky resin into their hives to combat pathogens. De Roode asks whether these astonishing behaviors are learned or innate and explains why, now more than ever, we need to apply the lessons from medicating animals--it can pave the way for healthier livestock, more sustainable habitats for wild pollinators, and a host of other benefits. Doctors by Nature takes readers into a realm often thought to be the exclusive domain of humans, exploring how scientists are turning to the medical knowledge of the animal kingdom to improve agriculture, create better lives for our pets, and develop new pharmaceutical drugs. Jaap de Roode is Samuel Candler Dobbs Professor of Biology at Emory University, where he is director of the Infectious Diseases across Scales Training Program, which trains graduate students in interdisciplinary science to study and control infectious disease. Caleb Zakarin is editor at the New Books Network. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Scott Dodson, professor of law at UC Law San Francisco, and Joseph Grundfest, professor of law and business emeritus at Stanford University, join the Business Scholarship Podcast to discuss their article The Missing Millions: Cy Pres in Federal Securities Class Actions. This episode is hosted by Andrew Jennings, associate professor of law at Emory University, and was edited by Dean Saridakis, a law student at Emory University.

In this episode, we dive into the rapidly evolving world of ambient listening AI in healthcare. From outpatient clinics to inpatient wards and operating rooms, this technology is reshaping how care is delivered, documented, and experienced. We explore how ambient listening AI is improving clinic flow by streamlining documentation and reducing interruptions, allowing clinicians to stay more present with their patients. The technology is increasingly adaptive to individual provider styles, learning preferences and workflows to deliver more personalized support. Plus, we share practical tips for new users to get the most out of their ambient listening AI systems from day one. Join us as we hear from experts on the front lines and debate the future of ambient listening AI in medicine—where the walls really do have ears, but for all the right reasons. Host:  - Nicole Petcka, MD – General Surgery Resident, Emory University, @npetcka2022 Guests:  - Samuel R. Torres Landa Fernández, MD – Minimally Invasive Surgery Fellow, Emory University  - Anastasios Nikolaos (Nick​) Panagopoulos, MD – Internal Medicine Resident, Emory University  - Joe Sharma, MD - McGarity Chair in Endocrine Surgery and Professor of Surgery, Vice-chair for Patient Safety, Quality and Innovation, Emory University  Resources:  Enhancing Accuracy of Operative Reports with Automated Artificial Intelligence Analysis of Surgical Video Khanna A, Wolf T, Frank I, Krueger A, Shah P, Sharma V, Gettman MT, Boorjian SA, Asselmann D, Tollefson MK. Enhancing Accuracy of Operative Reports with Automated Artificial Intelligence Analysis of Surgical Video. J Am Coll Surg. 2025 May 1;240(5):739-746. doi: 10.1097/XCS.0000000000001352. Epub 2025 Apr 16. PMID: 39918224. https://pubmed.ncbi.nlm.nih.gov/39918224/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Send us a textEric Diaz shares his journey of living with schizoaffective disorder and becoming an advocate for those with serious mental illness. Through finding the right medication, supportive communities, and creative outlets, Eric transformed from someone who couldn't leave his house to a published author helping others navigate similar challenges.• Diagnosed with schizoaffective disorder as a teenager but initially lacked insight into his condition• Participated in a clinical trial at Emory University that was crucial for starting treatment• Struggled with significant medication side effects before finding an effective treatment in 2011• Went from making fries at Wendy's to getting his GED and attending college• Became a Certified Peer Specialist to help others with mental health conditions• Recently published his novel "I Got Sober For This" exploring themes of mental illness• Now works as an employment specialist helping others with brain disorders find work• Credits stable housing, family support, and faith community as vital to his recovery• Emphasizes the importance of both medical treatment and social support systems• Currently focusing on writing and will be taking a screenwriting workshopKeep hope, keep going, and don't give up. Reach out to Eric at EricJDiaz1981@gmail.com if you'd like to learn more about his book or experiences.https://tonymantor.comhttps://Facebook.com/tonymantorhttps://instagram.com/tonymantorhttps://twitter.com/tonymantorhttps://youtube.com/tonymantormusicintro/outro music bed written by T. WildWhy Not Me the World music published by Mantor Music (BMI)

How happy are you when you buy auto insurance? If your answer is anything other than thrilled, you're not alone. In fact, years ago, a UK insurance company tried to convince us otherwise with their tagline “Quote Me Happy.” Spoiler alert: Nobody was happy. This raises a fascinating question: What role does advertising play in the customer experience, and why is there such a massive disconnect between the ads we see and what we actually get? In this episode, Colin Shaw and Professor Ryan Hamilton dive deep into the Great Expectation Gap—and they've brought in a special guest: Ben Shaw, Chief Strategy Officer at MullenLowe (and, fun fact, Colin's son). It turns out that years of heated Sunday lunch debates on advertising vs. CX have led to this moment!

The “Mission: Impossible” franchise is known for its big stunts, and the newest film is no exception. Producer Kathleen Davis talks to the film's stunt coordinator, Wade Eastwood, about the science behind one big underwater scene. Plus, psychologist Kenneth Carter joins Host Flora Lichtman to talk about what makes high-adrenaline adventurers tick.Take this questionnaire to see where you fall on the "sensation scale" Carter mentioned in this episode.Guests: Wade Eastwood is a stunt coordinator, stunt performer, and director in the film and television industry. He was the second unit director and stunt coordinator on "Mission: Impossible - The Final Reckoning."Dr. Kenneth Carter is a Professor of Psychology at Oxford College of Emory University, and the author of Buzz!: Inside the Minds of Thrill-Seekers, Daredevils, and Adrenaline Junkies.Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Buried treasure from the On Being archive!Krista writes of this conversation from the earliest pre-history of On Being: In the years in which I was on a whole new spiritual and intellectual adventure that changed the direction of my life — years which led to the creation of this show — I befriended a delightful, brilliant, straight-talking theologian named Roberta Bondi. She's now retired. At that point, she was on the faculty of the Candler School of Theology at Emory University. We were placed together as roommates at a five-day consultation. We fell deep into conversation about all kinds of things — life and love and God, a subject that fascinated us both. She'd written a book called Memories of God, and she'd written a series of books about the eccentric, dazzling wisdom of spiritual rebels and innovators known as the desert fathers and mothers of the 3rd century. These were people who believed that the established church — at that time the Church of Rome — had grown cold and remote from very heart of the impulses that brought it into the world in the first place: the rootedness in wisdom and not mere knowledge, the humility over against power, the core moral and spiritual values. Then, not that long ago in our world of institutions ceasing to make sense, someone I very much admire told me he was interested in picking up a practice of prayer. He had no idea how to begin or really even what this would be about – he just knew it was a longing he wanted to follow. The first thing that came to my mind to share with him is this somewhat eccentric, rich little half hour I had with Roberta in the earliest piloting of what eventually became On Being. Her wisdom about what it means to be a person who prays, in conversation and relationship with God, whoever God is and whatever God means, has formed me ever after. I am so delighted to share it now with you.Find an excellent transcript of this show, edited by humans, on our show page. Sign yourself and others up for The Pause to be on our mailing list for all things On Being and to receive Krista's monthly Saturday morning newsletter, including a heads-up on new episodes, special offerings, recommendations, and event invitations.BioRoberta Bondi is Professor Emeritus of Church History at Emory University. Her books include To Pray and to Love: Conversations on Prayer with the Early Church; Memories of God: Theological Reflections on a Life; and In Ordinary Time: Healing the Wounds of the Heart.

If you were asked to build a medical school from scratch, how would you do it? It's not a chance most of us get — but that was exactly the task given to our guest on this episode, Sharmila Makhija, MD, MBA. Dr. Makhija is a gynecologic oncologist by training, a clinician who has spent her career working with patients through some of life's most vulnerable and uncertain moments. She has also served as chair of obstetrics and gynecology at Montefiore Health System in New York, and before that, at Emory University. Most recently, and most notably, she is Founding Dean of the new Alice Walton School of Medicine in Bentonville, Arkansas. Here, she has taken on the ambitious and deeply human task of creating a medical school that doesn't just teach medicine, but reimagines its purpose. Over the course of our conversation, Dr. Makhija shares how her parents were instrumental to helping her find meaning in medicine, how she accompanies patients through serious illnesses, and the quiet but transformative power of presence. We then hear how she got the opportunity to create a new medical school — so new, in fact, that they are matriculating their first class in July 2025 — and her vision for preparing future doctors to face the technological, societal and professional uncertainties of medicine in the coming decades.In this episode, you'll hear about: 2:45 - What drew Dr. Makhija to a career in medicine, and specifically to her clinical focus in gynecological oncology 11:10 - How Dr. Makhija learned how to support patients through some of the hardest moments of their lives, and her advice on guiding patients through a poor prognosis 25:22 - Dr. Makhija's to becoming Founding Dean of the Alice Walton School of Medicine 32:00 - The school's approach to creating a new medical curriculum45:51 - Experiences that have surprised Dr. Makhija on her leadership journey48:38 - How Dr. Makhija plans to equip her students to face the rapid changes that are transforming the medical field Visit our website www.TheDoctorsArt.com where you can find transcripts of all episodes.If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2025